Mohammad Aldiabat, MD, MPH, is an Instructor in Medicine in the Department of Medicine, Division of Hospital Medicine. He obtained his medical degree from Jordan University of Science and Technology and completed his residency in internal medicine at NYC Health and Hospitals/Lincoln. Dr. Adiabat’s focus on geriatric inpatient care led him to pursue a Geriatrics Medicine Fellowship at NYU Langone, where he provided compassionate care to elderly patients hospitalized with various geriatric syndromes.
Dr. Aldiabat completed a Master of Public Health in Epidemiology and Biostatistics at the Harvard T.H. Chan School of Public Health to build advanced skills in clinical research and population health analysis, with research interests centered around gastroenterology and inflammatory bowel disease epidemiology and outcomes research in the elderly population.
Dr. Aldiabat’s primary goal is to investigate the epidemiology of gastroenterology and inflammatory bowel disease in the elderly population, with the ultimate aim of advancing their care and enhancing their quality of life.
Education
- MBBS: Jordan University of Science and Technology, Faculty of Medicine, Jordan (2018)
- Residency, Internal Medicine: Lincoln Medical Center/Weill Cornell Medicine, Bronx, NY (2022)
- MPH, Epidemiology: Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA (2024)
Board Certifications
- American Board of Internal Medicine
- American Board of Geriatrics Medicine
Clinical Interests
Hospital medicine, gastroenterology and inflammatory bowel diseases, epidemiology and outcomes research, determinants of public health.
Publications
Aldiabat M, Killani Y, Madi MY et al: INCREASED SUSCEPTIBILITY TO VIBRIO VULNIFICUS INFECTION IN PATIENTS WITH MASLD, CIRRHOSIS, AND CHRONIC LIVER DISEASES. The American Journal of the Medical Sciences 2025.
Kilani Y, Gonzalez Mosquera DA, Puelo PC, Aldiabat M, et al. The Impact of Cannabis Use in Gastroparesis: A Propensity Matched Analysis 41,374 gastroparesis patients. Am J Gastroenterol. 2025 Apr 8. doi: 10.14309/ajg.0000000000003479. Epub ahead of print. PMID: 40197432.
Kilani Y, Saqr A, Aldiabat M, et al. Frailty and Inflammatory Bowel Disease: A Nationwide Assessment. Gastro Hep Advances. 2024/07/14/ 2024; doi:https://doi.org/10.1016/j.gastha.2024.07.003
Aldiabat M, Alsakarneh S, Daniel T, et al. Inpatient outcomes of inflammatory bowel disease in hospitalized patients with COVID-19: analysis of a nationally representative sample. Baylor University Medical Center Proceedings.1-9. doi:10.1080/08998280.2024.2303402
Aldiabat M, Aleyadeh W, Rana T, et al. Burden of delirium on mortality and healthcare resource utilization in geriatric patients hospitalized for inflammatory bowel disease. Baylor University Medical Center Proceedings.1-7. doi:10.1080/08998280.2024.2342106
Aldiabat M, Kilani Y, Alahmad M, et al. Inpatient Outcomes of Gastric Antral Vascular Ectasia in Those with Aortic Stenosis: A Retrospective Study of 85,000 Hospitalizations. J Clin Gastroenterol. Oct 2, 2023; doi:10.1097/mcg.0000000000001932
Aldiabat M, Kilani Y, Arshad I, et al. Determinants and outcomes of acute pancreatitis in patients hospitalized for COVID-19: Early pandemic experience. Pancreatology. 2023/10/16/ 2023; doi:https://doi.org/10.1016/j.pan.2023.10.012
Kilani Y, Aldiabat M, Mubashir M, et al. Healthcare Utilization, Costs and Other Outcomes of Peroral Endoscopic Myotomy (POEM) Versus Heller Myotomy in the Inpatient Management of Achalasia in The United States: A 2016 to 2020 Nationwide Study. Foregut 2023:26345161231202957.
Abstracts
Aldiabat M, Yarur A, Peyrin-Biroulet L, et al. DOP102 Comparative effectiveness of risankizumab vs. ustekinumab in bio-naïve Crohn’s disease patients: A real-world multicentre retrospective cohort study. Journal of Crohn’s and Colitis. 2025;19(Supplement_1):i270-i271. doi:10.1093/ecco-jcc/jjae190.0141
Aldiabat M, Yarur A, Peyrin-Biroulet L, et al. P0982 Efficacy of upadacitinib in patients with Crohn’s disease and an ostomy: A matched retrospective real-world cohort analysis. Journal of Crohn’s and Colitis. 2025;19(Supplement_1):i1824-i1826. doi:10.1093/ecco-jcc/jjae190.1156
Alsakarneh S, Sqour H, Aldiabat M, et al. Gender and Racial Disparities in Liver Transplantation in the United States: Analysis From 69 Clinical Trials. Gastroenterology. 2024;166(5) :S-1544. Doi:10.1016/S0016-5085(24)03998-2
Aldiabat M, Cross Rk, Dassopoulos T, Lewis Jd, Ciorba Ma, Deepak P. Examining The Symptom Burden And Characteristics Of Elderly Inflammatory Bowel Disease Patients In The Study Of A Prospective Adult Research Cohort Of Ibd (Sparc Ibd). Gastroenterology. 2024;166(5):S-1440-S-1441. Doi:10.1016/S0016-5085(24)03758-2
Kilani Y, Aldiabat M, Vohra AA, et al. Mo1776 Inflammatory Bowel Diseases and Venous Thrombo-Embolism: A 2016 to 2020 Nationwide Analysis. Gastroenterology 2023, 164(6):S-905-S-906.
Aldiabat M, Aljabiri Y, Kilani Y, et al. Mortality And Morbidity Difference In Geriatrics Patients Hospitalized For Inflammatory Bowel Disease: Population-Based Age-Stratified Retrospective Study. Inflammatory Bowel Diseases. 2023;29(Supplement_1):S27-S28. Doi:10.1093/Ibd/Izac247.051
Musallam R, Abu-Shawer O, Aldiabat M, et al. 183 Prophylactic Proton Pump Inhibitors in Prevention of Marginal Ulcers After Gastric Bypass Surgery: A Systematic Review and Meta-Analysis. Gastroenterology 2023, 164(6) :S-1458.
Aldiabat M, Aljabiri Y, Alkhdour M, et al. Characteristics And Outcomes Of Geriatrics Patients Admitted For Upper Gastrointestinal Bleeding: A Population-Based Age-Stratified Retrospective Study. The American Journal Of Gastroenterology. 2022; 117(10S):e483-e484. Doi: 10.14309/01.Ajg.0000859428.07117.1a